| scholarly article | Q13442814 |
| P2093 | author name string | Kaplan J | |
| Haubrich R | |||
| Forthal DN | |||
| Tilles JG | |||
| Landucci G | |||
| Kuppermann BD | |||
| Keenan B | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 1338-1341 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients | |
| P478 | volume | 180 |
| Q27489000 | Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates |
| Q36600380 | Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. |
| Q35077677 | An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum |
| Q92538491 | An Inflammatory Story: Antibodies in Tuberculosis Comorbidities |
| Q26991572 | Antibody responses to envelope glycoproteins in HIV-1 infection |
| Q92511066 | Antibody-Induced Internalization of HIV-1 Env Proteins Limits Surface Expression of the Closed Conformation of Env |
| Q37396363 | Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection |
| Q81488462 | Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand |
| Q36763288 | Antibody-dependent cell-mediated virus inhibition antibody activity does not correlate with risk of HIV-1 superinfection |
| Q59352288 | Antibody-dependent cellular cytotoxicity in HIV infection |
| Q90000438 | Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants |
| Q35959717 | Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination |
| Q27320687 | Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells |
| Q40279352 | BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity |
| Q37261545 | Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition |
| Q35644696 | CD4 mimetics sensitize HIV-1-infected cells to ADCC. |
| Q37363561 | Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins |
| Q37002517 | Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies. |
| Q37460091 | Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women. |
| Q24538755 | Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients |
| Q34592776 | Compromised NK cell-mediated antibody-dependent cellular cytotoxicity in chronic SIV/SHIV infection |
| Q37347813 | Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. |
| Q92404984 | Deficient IL-2 Produced by Activated CD56+ T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection |
| Q90287020 | Differential Effect of Mucosal NKp44+ Innate Lymphoid Cells and Δγ Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques |
| Q37643973 | Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers |
| Q27675486 | Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding |
| Q52722794 | Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype. |
| Q38717198 | Engineering broadly neutralizing antibodies for HIV prevention and therapy |
| Q37646897 | Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG. |
| Q40529181 | Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b |
| Q38977425 | Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection |
| Q37426168 | Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses |
| Q36177537 | Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine |
| Q74012651 | Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection |
| Q37184296 | Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies |
| Q39108716 | HIV antibodies for treatment of HIV infection |
| Q34671009 | HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape |
| Q21131399 | HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads |
| Q35005192 | High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers |
| Q55022148 | High-resolution definition of humoral immune response correlates of effective immunity against HIV. |
| Q33620546 | Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection |
| Q35600028 | Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function |
| Q35925669 | Impaired NK Cell Activation and Chemotaxis toward Dendritic Cells Exposed to Complement-Opsonized HIV-1. |
| Q37191899 | Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody |
| Q41885613 | Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection |
| Q40366464 | Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses |
| Q37644079 | Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity |
| Q35167400 | Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies |
| Q38945522 | Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees |
| Q37333777 | Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection |
| Q45411655 | Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes |
| Q34788785 | Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins |
| Q64066666 | Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function |
| Q37677278 | Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles |
| Q33851763 | NK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaques |
| Q33741498 | NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. |
| Q40770807 | Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. |
| Q36797342 | Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity |
| Q36736588 | Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity |
| Q91582856 | Neutralization and beyond: Antibodies and HIV-1 acquisition |
| Q34550046 | Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success |
| Q33807535 | Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay |
| Q37113941 | Opportunities to exploit non-neutralizing HIV-specific antibody activity |
| Q50209602 | Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV. |
| Q35888710 | Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control |
| Q28703128 | Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions |
| Q42991296 | Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC). |
| Q92049906 | Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes |
| Q36538762 | Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity |
| Q36856960 | Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors |
| Q46632788 | Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors. |
| Q34992575 | The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals |
| Q37359263 | The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease |
| Q93079833 | Two Families of Env Antibodies Efficiently Engage Fc-Gamma Receptors and Eliminate HIV-1-Infected Cells |
Search more.